| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/02/2002 | EP0928187A4 Antibacterial composition |
| 10/02/2002 | EP0841946B1 Methods for treatment of allergic asthma |
| 10/02/2002 | EP0698018B1 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, their preparation and use |
| 10/02/2002 | EP0668933B1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 10/02/2002 | DE10114364A1 Verfahren zur Herstellung von antibiotischen Kompositen A process for producing antibiotic composites |
| 10/02/2002 | DE10114245A1 Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung Preparation and Use of an antibiotic / antibiotics preparation |
| 10/02/2002 | DE10114244A1 Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung Antibiotic / antibiotics preparation with retarding active ingredient release |
| 10/02/2002 | DE10113284A1 Adjuvans-Emulsion und Verfahren zu deren Verwendung Adjuvant emulsion, and methods of use thereof |
| 10/02/2002 | DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution |
| 10/02/2002 | DE10112325A1 Lagerstabile Fertiginfusionslösungen des Paracetamols Storage stable finished infusion solutions of paracetamol |
| 10/02/2002 | CN1372570A Modified exendin and exendin agonists |
| 10/02/2002 | CN1372472A Pernasally absorbable insulin preparations |
| 10/02/2002 | CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease |
| 10/02/2002 | CN1372463A Patches for external use |
| 10/02/2002 | CN1372462A Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 10/02/2002 | CN1372450A Enhanced wound converage to enhance wound healing |
| 10/02/2002 | CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof |
| 10/02/2002 | CN1091614C Bitterness-relieving agent |
| 10/02/2002 | CN1091597C Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
| 10/02/2002 | CN1091592C Biological cream for treating burn and its prepn. method |
| 10/02/2002 | CN1091591C Lipophilic carrier preparations |
| 10/02/2002 | CN1091590C Mucodhesive emulsion contg. cyclodextrin |
| 10/01/2002 | US6458937 Glycoconjugates and methods |
| 10/01/2002 | US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance |
| 10/01/2002 | US6458924 POLYPEPTIDE DRUG; ANTIDIABETIC AGENT; Liraglutide |
| 10/01/2002 | US6458842 Thyroid hormone or hormones; from about 40% to about 96% ethanol by volume; a ph adjusting agent so that the measured ph of the composition is from about 9 to about 12; and from about 4% to about 50% water by volume; for delivery |
| 10/01/2002 | US6458821 The novel substances are suitable for controlling diseases. interesting properties as potential neuroleptics and antidepressants |
| 10/01/2002 | US6458816 Anticancer agents |
| 10/01/2002 | US6458805 Antagonists; especially sodium salts |
| 10/01/2002 | US6458774 Pharmaceutical composition for local administration to treat a crural or decubitus ulcer, which comprises as a pharmaceutically active compounds with carriers |
| 10/01/2002 | US6458770 Parenteral formulations comprising carbamazepine or its derivatives |
| 10/01/2002 | US6458758 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 10/01/2002 | US6458401 Process for producing a powder containing crystalline particles of maltitol |
| 10/01/2002 | US6458400 Improving release of aroma or texture by adding glucopyranosyl-sorbitol; heating, exposing to vacuum, cooling |
| 10/01/2002 | US6458389 Microgranules containing cisplatin |
| 10/01/2002 | US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
| 10/01/2002 | US6458381 Lipids and their use, for example, in liposomes |
| 10/01/2002 | US6458373 Emulsion vehicle for poorly soluble drugs |
| 10/01/2002 | US6458355 Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates |
| 10/01/2002 | US6458347 Drug complex |
| 10/01/2002 | US6458343 Quaternary compounds, compositions containing them, and uses thereof |
| 10/01/2002 | US6458338 Amino acid stabilized medicinal aerosol formulations |
| 10/01/2002 | CA2077670C Method for enhancing antibody transport through capillary barriers |
| 10/01/2002 | CA2069244C Drug-containing protein-bonded liposome |
| 10/01/2002 | CA2068632C Nanocrystalline magnetic iron oxide particles, processes for their preparation and their use in medical diagnostics and therapy |
| 09/26/2002 | WO2002075275A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 09/26/2002 | WO2002074807A2 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | WO2002074806A2 New interferon beta-like molecules |
| 09/26/2002 | WO2002074794A2 Compositions useful in gene therapy |
| 09/26/2002 | WO2002074736A1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 09/26/2002 | WO2002074348A1 Dry powder compositions comprising labelled particles for inhalation |
| 09/26/2002 | WO2002074344A2 Peg-conjugates of hgt-nk4 |
| 09/26/2002 | WO2002074340A1 Process for producing sustained release preparation |
| 09/26/2002 | WO2002074339A1 Deveice and method for the photodynamic diagnosis of tumor tissue |
| 09/26/2002 | WO2002074336A2 Influenza vaccine formulations for intradermal delivery |
| 09/26/2002 | WO2002074332A2 Method to enhance the immunogenicity of an antigen |
| 09/26/2002 | WO2002074327A2 Compositions and methods for treating gonadotrophin related illnesses |
| 09/26/2002 | WO2002074325A1 Patch for transcutaneous immunization |
| 09/26/2002 | WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| 09/26/2002 | WO2002074316A1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| 09/26/2002 | WO2002074310A2 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
| 09/26/2002 | WO2002074308A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 09/26/2002 | WO2002074305A1 Use of a substantially cell membrane impermeable compound for treating arthritis |
| 09/26/2002 | WO2002074301A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/26/2002 | WO2002074286A1 Transdermal patch for administering fentanyl |
| 09/26/2002 | WO2002074283A1 Adjuvant emulsion and method of using said emulsion |
| 09/26/2002 | WO2002074282A1 New composition |
| 09/26/2002 | WO2002074281A1 Ophthalmic compositions and use thereof |
| 09/26/2002 | WO2002074275A2 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces |
| 09/26/2002 | WO2002074247A2 Pharmaceutical formulations for sustained release |
| 09/26/2002 | WO2002074238A2 Water soluble and palatable complexes |
| 09/26/2002 | WO2002074200A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 09/26/2002 | WO2002074193A2 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES |
| 09/26/2002 | WO2002074171A1 Fluorescent cobalamins and uses thereof |
| 09/26/2002 | WO2002074034A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 09/26/2002 | WO2002062356A3 Monovalent-selective cation exchangers as oral sorbent therapy |
| 09/26/2002 | WO2002056843A3 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields |
| 09/26/2002 | WO2002045752A3 Dermal anti-inflammatory composition |
| 09/26/2002 | WO2002038609A3 Apolipoprotein conjugates |
| 09/26/2002 | WO2002036167A8 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/26/2002 | WO2002032461A3 Protein c or activated protein c-like molecules |
| 09/26/2002 | WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation |
| 09/26/2002 | WO2002026277A3 Stabilized hydrogen peroxide solutions |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002015880A3 Powdered mannitol and mannitol-containing compositions |
| 09/26/2002 | WO2001090159B1 Compositions and methods for delivery of a molecule into a cell |
| 09/26/2002 | WO2001085093A9 Compounds and methods for modulating cerebral amyloid angiopathy |
| 09/26/2002 | WO2001080837A2 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 09/26/2002 | WO2001076568A3 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 09/26/2002 | WO2001074338A1 Transdermal therapeutic system for the delivery of lerisetron |
| 09/26/2002 | WO2001040370A3 Ionically crosslinked hydrogels with adjustable gelation time |
| 09/26/2002 | WO2001034119A9 Inhibitors of crystallization in a solid dispersion |
| 09/26/2002 | WO2000061112A3 Solubilized pharmaceutical composition for parenteral administration |
| 09/26/2002 | US20020137884 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 09/26/2002 | US20020137814 Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same |
| 09/26/2002 | US20020137803 Composition and method for delivering active agents |
| 09/26/2002 | US20020137771 Mixing benzimidazole derivatives with basic inorganic salt stabilizing agent, granulating and enteric coating granules; gastric acid secretion inhibitors |
| 09/26/2002 | US20020137765 Sustained release formulations for growth hormone secretagogues |
| 09/26/2002 | US20020137729 For minimizing the absorption of triglycerides and fats in the gastrointestinal tract; fat binding; treating obesity |
| 09/26/2002 | US20020137717 Use of chimeric mutational vectors to change endogenous nucleotide sequences in solid tissues |